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This study has all the limitations of every retrospective
data collection. In addition, the sample size is rather small,
particularly with regard to patients with ALP.Moreover, be-
cause 67.5% of the patients had an echocardiographic
examination performed at other institutions, we cannot ex-
clude that the rate of recurrent MR in those patients might
have been underestimated. However, this event seems rather
unlikely because of the consistency between the good echo-
cardiographic late outcomes reported and the very satisfac-
tory clinical conditions described by the patients. In
addition, no consistent data were available in terms of left
ventricular dimensions, right ventricular function, and sys-
tolic pulmonary artery pressure at follow-up, and therefore
they could not be analyzed and compared with preoperative
values. Another limitation of this study is represented by the
fact that the causes of recurrent MR remain unknown in
most patients either because they were reoperated at other
institutions or because this information could not be re-
trieved from the operative reports. Last, as we emphasized
earlier, this study includes a selected group of patients,
and this needs to be taken into account when looking at
the late outcomes of this technique. Only patients with de-
generativeMR resulting primarily fromBLP or ALP treated
with a DO repair combined with ring annuloplasty were in-
cluded. The results reported in this series, therefore, cannot
be extended to patients submitted to DO technique without
concomitant annuloplasty and to cases of MR resulting
from etiologies other than degenerative.
CONCLUSION
In conclusion, our clinical and echocardiographic data
confirm that the DO mitral valve repair, combined with
ring annuloplasty, provides very satisfactory long-term re-
sults in patients with degenerative MR in the setting of
BLP and ALP.
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Dr Donald D. Glower (Durham, NC). You have just heard De
Bonis and colleagues present what is probably one of the world’s
longest and largest series of edge-to-edge or double-orifice repairs
for mitral valve prolapse. This series is important in documenting
the results that can be achieved in selected patients using yet an-
other potentially powerful tool for mitral valve repair.
Personally, it took me several attempts to get the feel for this
technique, but over the past 6 years I found the technique to be use-
ful, even in repairing most cases of posterior leaflet prolapse, with-
out leaflet resection. I feel that the edge-to-edge repair may
minimize the potential for SAM in large myxomatous valves re-
paired without leaflet resection where even a 40-mm ring may
be too small in some of those patients, and the edge-to-edge repair
may add an additional safety factor in ensuring good long-term
leaflet coaptation, particularly in patients with complex myxoma-
tous valves. I have 3 questions for you.
Could you clarify, based on your experience to date and if we
limit ourselves to patients with prolapse only, what would yougery c November 2012
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the edge-to-edge or double-orifice technique?
Dr De Bonis. Sorry, I can’t really hear you. Contraindications?
Dr Glower. I think you have talked about in the past that you
would not use this in rings less than 30 mm. Is there anything
you would see about a patient that would cause you not to use
this technique?
Dr De Bonis. I would say that one contraindication is annular
calcification.We excluded those patients from this series. At the be-
ginning, we thought that the edge-to-edge technique could be a very
good solution in patients with a heavily calcified annulus—a simple
technique, a suture between the 2 leaflets that we hoped could be
long-lasting. That is not true. So one contraindication is annular cal-
cification.Wewould now decalcify the annulus and use this or other
techniques after decalcification or replace the valve.
Another contraindication is the presence, of course, of a small
annulus. If you have to put in a small ring, then the risk of stenosis
increases, but this is seen in a relatively small number of patients. If
you ask me which ring we have been using, we have been using in
the degenerative setting semirigid, complete rings from30 up to 40.
Most of the patients have got the ring 36 or 38, but there is a limited
number of patients with No. 30 rings. In those patients, the residual
mitral valve area is borderline, which means between 2 cm2and 2.5
cm2, but we had no major problems in terms of mitral stenosis.
Dr Glower. The data you have presented were patients all oper-
atedmore than 10 years ago, up to the year 2000. Have you changed
your technique since the year 2000 or your selection criteria?
Dr De Bonis. There have been some changes. In terms of rings,
for instance, we are not using anymore a complete ring. We are us-
ing almost exclusively a partial posterior band from trigone to trig-
one. I don’t think this is really going to make a major difference in
terms of long-term results. We didn’t find any difference between
the complete ring or the partial ring. So that is one modification we
did. Moreover, we have been using the edge-to-edge technique in
a less aggressive way than we were doing before. We are not using
this technique anymore in rheumatic disease, and we have been us-
ing artificial chordae or conventional reconstructions also for Bar-
low’s disease.
But still, this is a technique which is in our armamentarium and
we use it anytime we think it can be particularly useful—for in-
stance, when you need a quick operation, when you have to do
multiple procedures, in case of a particularly complex repair, or
when you have opposite lesions on facing segments of the anterior
and posterior leaflets. Those are a relatively small number of pa-
tients, but they do exist. For instance, you can have an important
prolapse of the anterior leaflet combined with hypoplasia or teth-
ering of the posterior one resulting from dilatation of the left ven-
tricle. Those types of opposing lesions can be very well addressed
by the edge-to-edge technique.
Dr Glower. You mentioned that you started out applying the
technique even to patients with posterior leaflet prolapse but
have backed off of that. Do you think there is a role for this?
Dr De Bonis. That is a very interesting question. I would like to
emphasize that this is a very early series of patients. So, of course,
there is a lot of learning curve.But as it has been reported in the slides
and in the paper, 10 patients had isolated posterior leaflet prolapse.
Nowadays wewould not use the edge-to-edge technique for isolated
prolapse of the posterior leaflet. We use conventional techniques,The Journal of Thoracic and Carfolding, sliding, whatever. The results at long term of the classical
Carpentier techniques in this setting are extremely good.
But what is interesting is that none of the patients with posterior
leaflet prolapse reported in this series have been reoperated or did
have recurrent MR. Among those patients, 1 died, not from
a valve-related cause, but the other 9 patients have a perfectly com-
petent valve.
So the question is: Does it work? I think so; I think it does work.
Do you have to use it? We don’t, but it is up to the surgeon. And I
don’t see a specific contraindication to use it.
Dr Glower. Thank you. Excellent paper.
DrWalaa A. Saber (Cairo, Egypt). Can you tell us, please, if in
all your patients the edge-to-edge repair was central? In other
words, the double orifice is always equal or sometimes you have
unequal orifices?
Dr De Bonis. Thank you very much for your question. I would
like to emphasize that this series includes just patients with double-
orifice mitral valve repair. So this series is just a series of patients
with central edge-to-edge stitch. Those with commissural edge-to-
edge have been excluded. We have reported them and published.
We have had very good results with the commissural edge-to-
edge technique. In that specific setting, which is commissural pro-
lapse, the edge-to-edge technique remains the first choice in our
hands, and the results are really very good.
When you perform a central edge-to-edge technique, you have
to keep in mind that your suture has to address the lesions, which
means that if you have the flail that is between A1 and A2, it is not
necessary to put the stitches in the central portion of A2, because
you don’t want to leave the flailing segment that is closer to A1. So
your suturemust be asymmetric; otherwise, youwill not get a com-
petent valve. So you can end up with orifices that are of different
sizes, but this doesn’t matter, because computational models have
shown that the valve is going to behave as a valve that has an area
that is the sum of the 2 orifices. So it doesn’t matter if one orifice is
2 cm2 and the other one is 1 cm2 or they are both 2 cm2.
Did I answer your question?
Dr Saber. Yes. Thank you.
Dr Robert A. Dion (Genk, Belgium). Congratulations, Mi-
chele, for a very nice presentation. I just have 2 small questions.
First, did you ever do a stress test to measure the gradient at exer-
cise? Second question: How do you decide that a ring is too small
for these particular patients?
Dr De Bonis. Thank you very much, Dr Dion. Indeed, I did not
show that for time reasons and also because that is not part of this
study, but 30 of those patients, exactly those patients, with ring and
edge-to-edge repair, were submitted to exercise echocardiography.
This paper has been published in the Journal of Heart Valve Dis-
ease in 2002, first name is Dr Agricola, and there we addressed
your question.
So we put the patients on the bicycle, we did an exercise test,
and the mean area at baseline was 3.2 cm2. During exercise it be-
came, at the peak of the exercise, 4.3 cm2. In terms of gradient, the
mean gradient at baseline was 2.8 mm Hg and it increased to 4.6
mm Hg. We never found pulmonary hypertension, so we excluded
the possibility of stenosis.
Addressing your second question, when you decide the ring is
too small, that is very important. It is really a matter of experience.
Just by looking at the 2 orifices with the forceps when you havediovascular Surgery c Volume 144, Number 5 1025
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too small. In addition, it is even easier if you just put a Hegar in-
side. So if I am putting a 30-mm ring, I start to be concerned,1026 The Journal of Thoracic and Cardiovascular Surbut, in case of doubt, I can always measure the size of the orifices.
For instance, if I can put in a Hegar which is No. 20, there is no risk
of stenosis at all.gery c November 2012
